-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Initiates Coverage On Virax Biolabs Group with Buy Rating, Announces Price Target of $3

Benzinga·03/31/2025 11:00:01
Listen to the news
HC Wainwright & Co. analyst Yi Chen initiates coverage on Virax Biolabs Group (NASDAQ:VRAX) with a Buy rating and announces Price Target of $3.